Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Health technology assessment for levetiracetam in the treatment of newly diagnosed epilepsy in the South African Public Health Sector
Epilepsy, a chronic neurological disorder has an estimated prevalence of between 0.4% and 1.0% globally, and 1% in South Africa. Epilepsy has multiple underlying causes including head injuries, vascular insults, hippocampal sclerosis, cortical dysgenesis, drug or alcohol abuse and infectious disease...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Health Economics Unit
2020
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!